I’m in the middle of my marketing class right now. Clearly, I am paying attention.
Here are some links to news and updates in the Myeloma world. I’ll explain them in further detail when I get home!
Carflizomib gets fast-track designation from FDA for treatment of refractory/relapsed Multiple Myeloma patients. Yay! Click HERE
Revlimid Maintenance and Secondary Cancers – More details emerge. BOOO! Click HERE
Why should you take Dex(amethasone) with food? Click HERE